{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:11:35Z","timestamp":1783836695353,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.therap.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:51:55Z","timestamp":1643021515000},"page":"571-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Utilisation de la k\u00e9tamine chez les patients ambulatoires\u00a0: que pouvons-nous apprendre des pratiques actuelles\u00a0?"],"prefix":"10.1016","volume":"77","author":[{"given":"Antony","family":"Salvati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Daveluy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Claverie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Miremont-Salam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lisabeth","family":"Frauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2022.01.011_bib0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009749509095181","article-title":"Pain analysis in patients with fibromyalgia\u00a0: effects of intravenous morphine, lidocaine, and ketamine","volume":"24","author":"S\u00f6rensen","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.therap.2022.01.011_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2003.07.001","article-title":"Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"108","author":"Carr","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.therap.2022.01.011_bib0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13341-010-0019-9","article-title":"Recommandations formalis\u00e9es d\u2019experts 2010\u00a0: s\u00e9dation et analg\u00e9sie en structure d\u2019urgence (r\u00e9actualisation de la conf\u00e9rence d\u2019experts de la SFAR de 1999)","volume":"1","author":"Vivien","year":"2011","journal-title":"Ann Fr Med Urgence"},{"key":"10.1016\/j.therap.2022.01.011_bib0140","first-page":"421","article-title":"R\u00e9actualisation de la recommandation sur la douleur postop\u00e9ratoire","volume":"2","author":"Aubrun","year":"2016","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.therap.2022.01.011_bib0145","series-title":"Douleur rebelle en situation palliative avanc\u00e9e chez l\u2019adulte. Recommandation de bonne pratique","author":"Afssaps. Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9","year":"2010"},{"key":"10.1016\/j.therap.2022.01.011_bib0150","series-title":"Antalgie des douleurs rebelles et pratiques s\u00e9datives chez l\u2019adulte\u202f: prise en charge m\u00e9dicamenteuse en situations palliatives jusqu\u2019en fin de vie. Recommandation de bonne pratique","author":"HAS. Haute Autorit\u00e9 de sant\u00e9","year":"2020"},{"key":"10.1016\/j.therap.2022.01.011_bib0155","series-title":"Commission nationale des stup\u00e9fiants et des psychotropes","author":"ANSM. Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9","year":"2012"},{"key":"10.1016\/j.therap.2022.01.011_bib0160","first-page":"75","article-title":"Prise en charge ambulatoire des patients atteints de fibromyalgie par k\u00e9tamine par voie sous-cutan\u00e9e\u00a0: que nous apprend la pratique\u00a0? \u00c9tude r\u00e9trospective observationnelle au CHU de Grenoble","volume":"14","author":"Logerot","year":"2013","journal-title":"Douleurs"},{"key":"10.1016\/j.therap.2022.01.011_bib0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0304-3959(99)00308-5","article-title":"Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients","volume":"85","author":"Graven-Nielsen","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.therap.2022.01.011_bib0170","doi-asserted-by":"crossref","first-page":"A146","DOI":"10.1016\/j.annfar.2014.07.235","article-title":"Utilisation ambulatoire de la k\u00e9tamine per os en douleur chronique\u00a0: \u00e9tude r\u00e9trospective d\u2019une s\u00e9rie de 51\u00a0patients","volume":"33","author":"Mion","year":"2014","journal-title":"Ann Fr Anesth"},{"key":"10.1016\/j.therap.2022.01.011_bib0175","first-page":"62","article-title":"Deux cas de syndrome d\u2019Ehlers Danlos avec manifestations douloureuses rebelles am\u00e9lior\u00e9es par k\u00e9tamine","volume":"8","author":"Dumolard","year":"2007","journal-title":"Douleur"},{"key":"10.1016\/j.therap.2022.01.011_bib0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.therap.2018.09.064","article-title":"Complications uro-n\u00e9phrologiques avec les antagonistes NMDA\u00a0: illustration avec la k\u00e9tamine","volume":"73","author":"Micallef","year":"2018","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.01.011_bib0185","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1007\/s11033-014-3616-5","article-title":"Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier","volume":"41","author":"Gu","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.therap.2022.01.011_bib0190","article-title":"K\u00e9tamine\u202f: risque d\u2019atteintes uro-n\u00e9phrologiques, endocriniennes et h\u00e9patiques graves lors d\u2019utilisations prolong\u00e9es et\/ou \u00e0 doses \u00e9lev\u00e9es \u2013 Rappel de l\u2019importance du respect du bon usage","author":"ANSM. Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9","year":"2018","journal-title":"Lett Prof Sante"},{"key":"10.1016\/j.therap.2022.01.011_bib0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.therap.2018.06.001","article-title":"K\u00e9tamine et douleur chronique\u00a0: une revue narrative de son efficacit\u00e9 et s\u00e9curit\u00e9","volume":"73","author":"Pickering","year":"2018","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.01.011_bib0200","series-title":"Arr\u00eat\u00e9 du 19 janvier 2017 modifiant l\u2019arr\u00eat\u00e9 du 22 f\u00e9vrier 1990 fixant la liste des substances class\u00e9es comme stup\u00e9fiants","author":"L\u00e9gifrance","year":"2017"},{"key":"10.1016\/j.therap.2022.01.011_bib0205","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejp.624","article-title":"Efficacy and safety of oral ketamine for the relief of intractable chronic pain: a retrospective 5-year study of 51\u00a0patients","volume":"19","author":"Marchetti","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.therap.2022.01.011_bib0210","first-page":"207","article-title":"Management of neuropathic chronic pain with methadone combined with ketamine: a randomized, double blind, active-controlled clinical trial","volume":"20","author":"Rigo","year":"2017","journal-title":"Pain Phys"},{"key":"10.1016\/j.therap.2022.01.011_bib0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpain.2009.09.005","article-title":"Use of oral ketamine in chronic pain management: a review","volume":"14","author":"Blonk","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.therap.2022.01.011_bib0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0304-3959(99)00117-7","article-title":"N of 1\u00a0randomised controlled trials of oral ketamine in patients with chronic pain","volume":"83","author":"Haines","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.therap.2022.01.011_bib0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12094","article-title":"Ketamine for chronic pain: risks and benefits","volume":"77","author":"Niesters","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2022.01.011_bib0230","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.pain.2011.03.026","article-title":"Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain inCRPS type 1\u00a0patients: a report of 3\u00a0cases","volume":"152","author":"Noppers","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.therap.2022.01.011_bib0235","article-title":"Toxicit\u00e9 chronique de la k\u00e9tamine","author":"INSPQ. Institut national de sant\u00e9 publique Qu\u00e9bec","year":"2013","journal-title":"Bull Inf Toxicol"},{"key":"10.1016\/j.therap.2022.01.011_bib0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Independent scientific committee on drugs. Ketamine use: a review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:23Z","timestamp":1758567323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595722000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0040595722000130"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2022.01.011","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilisation de la k\u00e9tamine chez les patients ambulatoires\u00a0: que pouvons-nous apprendre des pratiques actuelles\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}